Skip to main content
. Author manuscript; available in PMC: 2016 May 4.
Published in final edited form as: Neuropharmacology. 2015 Oct 19;101:490–505. doi: 10.1016/j.neuropharm.2015.10.020

Figure 6. Effects of SCH58261, an A2A adenosine receptor antagonist, on locomotor-related output parameters.

Figure 6

A: time-course plots showing no effects on either locomotor burst amplitude, motor burst duration and cycle period after the application of SCH58261 (1μM, 20 minutes; n = 5). Each point represents 1 minute worth of recording. B: pooled data, averaged of 5 minutes worth of recordings in each condition, showing no effects on either locomotor burst amplitude, motor burst duration and cycle period after the application of SCH58261 (1μM, 20 minutes; n = 5). *Significantly different from control.